An Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP)

Investigator, New York

Investigator, New York

Investigator, Washington D.C.

Investigator, Bethesda

Investigator, Riverdale

Investigator, Atlanta

Investigator, Jacksonville

Investigator, Boynton Beach

Investigator, Cleveland

Investigator, Kansas City

Investigator, Jefferson City

Investigator, Metairie

Investigator, San Antonio

Investigator, Salt Lake City

Investigator, Los Angeles

Investigator, Anaheim

Investigator, Seattle

Investigator, Boston

Investigator, New Brunswick